Cambridge Financial Group Inc. trimmed its holdings in UnitedHealth Group Inc (NYSE:UNH) by 1.8% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 33,346 shares of the healthcare conglomerate’s stock after selling 596 shares during the period. UnitedHealth Group comprises approximately 3.6% of Cambridge Financial Group Inc.’s holdings, making the stock its 8th largest holding. Cambridge Financial Group Inc.’s holdings in UnitedHealth Group were worth $7,351,000 as of its most recent SEC filing.
Several other institutional investors and hedge funds have also made changes to their positions in UNH. Exane Derivatives raised its position in shares of UnitedHealth Group by 15,333.3% during the 4th quarter. Exane Derivatives now owns 463 shares of the healthcare conglomerate’s stock valued at $102,000 after acquiring an additional 460 shares in the last quarter. Bruderman Asset Management LLC acquired a new stake in shares of UnitedHealth Group during the 2nd quarter valued at approximately $114,000. Acrospire Investment Management LLC raised its position in shares of UnitedHealth Group by 130.7% during the 2nd quarter. Acrospire Investment Management LLC now owns 706 shares of the healthcare conglomerate’s stock valued at $131,000 after acquiring an additional 400 shares in the last quarter. Jacobi Capital Management LLC raised its position in shares of UnitedHealth Group by 6.6% during the 2nd quarter. Jacobi Capital Management LLC now owns 729 shares of the healthcare conglomerate’s stock valued at $136,000 after acquiring an additional 45 shares in the last quarter. Finally, Intellectus Partners LLC raised its position in shares of UnitedHealth Group by 18.2% during the 2nd quarter. Intellectus Partners LLC now owns 818 shares of the healthcare conglomerate’s stock valued at $152,000 after acquiring an additional 126 shares in the last quarter. 86.83% of the stock is currently owned by institutional investors.
In other news, Director Richard T. Burke sold 10,400 shares of the stock in a transaction on Thursday, March 1st. The stock was sold at an average price of $229.87, for a total value of $2,390,648.00. Following the completion of the transaction, the director now owns 1,781,657 shares of the company’s stock, valued at $409,549,494.59. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, Director Kenneth Irwin Shine sold 198 shares of the stock in a transaction on Friday, January 19th. The stock was sold at an average price of $242.55, for a total value of $48,024.90. Following the completion of the transaction, the director now directly owns 1,790,567 shares of the company’s stock, valued at approximately $434,302,025.85. The disclosure for this sale can be found here. In the last three months, insiders sold 53,196 shares of company stock valued at $12,291,179. Company insiders own 0.89% of the company’s stock.
UnitedHealth Group Inc (NYSE UNH) opened at $222.77 on Tuesday. The company has a market capitalization of $215,570.00, a price-to-earnings ratio of 23.45, a P/E/G ratio of 1.31 and a beta of 0.74. The company has a debt-to-equity ratio of 0.58, a quick ratio of 0.73 and a current ratio of 0.73. UnitedHealth Group Inc has a 52 week low of $162.74 and a 52 week high of $250.79.
UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Tuesday, January 16th. The healthcare conglomerate reported $2.59 EPS for the quarter, topping the Zacks’ consensus estimate of $2.50 by $0.09. UnitedHealth Group had a return on equity of 21.29% and a net margin of 5.25%. The firm had revenue of $52.06 billion during the quarter, compared to the consensus estimate of $51.57 billion. During the same period in the prior year, the business earned $2.11 EPS. The firm’s revenue was up 9.5% on a year-over-year basis. analysts anticipate that UnitedHealth Group Inc will post 12.51 earnings per share for the current year.
The firm also recently declared a quarterly dividend, which will be paid on Tuesday, March 20th. Stockholders of record on Friday, March 9th will be paid a $0.75 dividend. The ex-dividend date is Thursday, March 8th. This represents a $3.00 annualized dividend and a dividend yield of 1.35%. UnitedHealth Group’s payout ratio is 31.58%.
COPYRIGHT VIOLATION NOTICE: This story was originally reported by American Banking News and is the sole property of of American Banking News. If you are reading this story on another publication, it was stolen and republished in violation of United States & international trademark & copyright laws. The correct version of this story can be accessed at https://www.americanbankingnews.com/2018/03/13/cambridge-financial-group-inc-has-7-35-million-holdings-in-unitedhealth-group-inc-unh.html.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.